ictc: session 1 - therapeutic landscape in the treatment of relapsed b cell lympoma
Published 5 years ago • 163 plays • Length 26:53Download video MP4
Download video MP3
Similar videos
-
37:42
ictc: session 1 - therapeutic landscape in the treatment of relapsed myeloma
-
19:47
new approached in management of relapsed/refractory dlbcl
-
32:04
htlv-1 associated malignancies: from diagnosis to treatment
-
8:54
stephen j. schuster, md: tisagenlecleucel promising in relapsed/refractory dlbcl
-
9:09
debate: is maintenance therapy of value following frontline treatment for advanced dlbcl - yes
-
49:10
car t cell therapy for relapsed lymphoma: journey from being a patient to a survivor
-
11:08
regulatory landscape for car t-cell therapy
-
21:01
lymphoma update - treatments - part 1
-
6:08
relapsed/refractory dlbcl treatment landscape
-
1:55
novel biological therapies for managing non-hodgkin lymphoma
-
20:45
dr. sarah milgrom: radiation therapy in the management of relapsed/refractory lymphoma
-
1:28
first-in-human study of iph4102 for relapsed cutaneous t-cell lymphoma
-
54:11
car t-cells in lymphoma: new advances and practical aspects
-
2:18
brentuximib vedotin therapy for hodgkin lymphoma
-
1:56
the need for new treatment strategies for patients with dlbcl
-
27:49
hodgkin disease: the past, the present, and the future
-
3:01
how the treatment of dlbcl and fl are changing in the uk
-
1:32
management and outcomes of elderly patients with lbcl